Company CVAbout Novartis India Ltd 
Novartis India Ltd
Small Cap
Pharmaceuticals & Drugs
Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health.
Company Coordinates
Company Details
The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E) Mumbai Maharashtra : 400051
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 14.07 Cr
Number of Shares
2.81 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Sep-2016
2.81
14.07
-3820000
5
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 6 Schemes (0.0%)
FIIs
Held by 18 FIIs (0.19%)
Promoter with highest holding
Novartis Ag (70.68%)
Highest Public shareholder
Atul Limited (1.52%)
Individual Investors Holdings
23.01%
Board of Directors
Management
Designation
Remuneration
C Snook
Chairman (Non-Executive)
0
Jai Hiremath
Independent Director
10.0 lacs
Sandra Martryes
Independent Director
10.0 lacs
Sanjay Murdeshwar
Vice Chairman & M.D.
1.01 cr
SANKER PARAMESWARAN
Independent Director
10.0 lacs
Nikhil Malpani
Company Sec. & Compli. Officer
0
Shilpa Joshi
Whole Time Director & CFO
38.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals and Medical Goods - Traded
530.79
90.07%
Commission
39.00
6.62%
Services
18.18
3.08%
Pharmaceuticals and Medical Goods - Traded
Pharmaceuticals and Medical Goods - Traded
Commission
Commission
Services
Services
Stock DNARevenue and Profits:
Net Sales:
93 Cr
(Quarterly Results - Dec 2024)
Net Profit:
25 Cr
Pharmaceuticals & Drugs
INR 1,957 Cr (Small Cap)
22.00
33
3.20%
-0.81
11.83%
2.65
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
